Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01951820 · ClinicalTrials.gov registry record · Phase 4
Comparison of Two Topical Anesthetics: Benzocaine Versus Pliaglis
A Phase 4 study, sponsored by University of Michigan.
- Completed
- Registry status
- Phase 4
- Development phase
- 64
- Enrollment target
NCT01951820 is a Phase 4 study that has completed, run by University of Michigan. The registered enrollment target is 64 participants.
The verdict
NCT01951820, a Phase 4 study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 64 participants
- Enrollment target
Study Summary
The efficacy of the topical anesthetics will be determined by how much pain the patient felt (using a Heft-Parker pain analog scale) upon needle penetration.
Interventions
- DRUG Benzocaine
- DRUG Pliaglis
- DRUG Articaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2013-08 |
| Est. Completion | 2014-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01951820
The ClinicalTrials.gov registry entry for NCT01951820 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Benzocaine is the first listed.
NCT01951820 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01951820 about?
NCT01951820 is a clinical study titled "Comparison of Two Topical Anesthetics: Benzocaine Versus Pliaglis". The efficacy of the topical anesthetics will be determined by how much pain the patient felt (using a Heft-Parker pain analog scale) upon needle penetration.
What is the current status of trial NCT01951820?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 64 participants. The study started on 2013-08. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01951820?
The interventions under investigation include: Benzocaine (DRUG), Pliaglis (DRUG), Articaine (DRUG).
Who is sponsoring clinical trial NCT01951820?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.